The Human Blood Plasma Fractionation Market is witnessing a significant surge as the global healthcare infrastructure prioritizes life-saving therapeutic proteins and immunoglobulins. With the growing prevalence of chronic diseases, autoimmune disorders, and rare blood conditions, the demand for plasma-derived therapies has escalated rapidly. Advances in biotechnology and more efficient...